Genomics of Inflammation and Immunity
We use high-throughput genetic and genomic screens, plus immunological assays, to identify drug targets and deliver personalised medicine for patients with immune-mediated disease, with a particular focus on inflammatory bowel disease (IBD) and primary sclerosing cholangitis (PSC).
